GKOS

Glaukos Corporation

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$246.03

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %1.1 / %30

Non-compliant assets / Total market cap %3.2 / %30

Non-compliant revenue / Total income %1.3 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor.

Website

Analysis (Turkish): GKOS Hissesi Caiz mi, Helal mi? Glaukos Corporation Katılım Analizi